# Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis

> **NCT05871463** · PHASE2 · UNKNOWN · sponsor: **Research Institute for Gastroenterology and Liver Diseases (RIGLD)** · enrollment: 15 (estimated)

## Conditions studied

- Decompensated Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** MSC-derived exosomes

## Key facts

- **NCT ID:** NCT05871463
- **Lead sponsor:** Research Institute for Gastroenterology and Liver Diseases (RIGLD)
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-26
- **Primary completion:** 2023-08-11
- **Final completion:** 2023-12-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871463, "Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05871463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*